Annals of Dermatology · 2010 · 60 citations · 28 references
MedicineDermatologyBehavioral EpidemiologyClinical EpidemiologyEpidemiologyCardiovascular DiseaseChronic Disease EpidemiologyLipoprotein AnalysisMetabolic SyndromePsoriatic ArthritisCardiovascular Disease IncidenceCardiovascular Disease PrevalenceCardiovascular Risk MarkersLipid Profile AnalysisLow-density Lipoprotein ParticlesPlasma Cholesterol LevelsPrevalence EstimationPsoriatic Disease
BACKGROUND: Previous studies have shown a possible association between psoriasis and cardiovascular risk factors. OBJECTIVE: We wanted to study the association between psoriasis and cardiovascular risk factors, including metabolic syndrome. METHODS: We determined the relationship of psoriasis with the cardiovascular risk factors, metabolic syndrome and cardiovascular disease. For the proper level of low-density lipoprotein (LDL) cholesterol, we calculated the proportion of psoriasis patients who needed lifestyle changes or drug therapy. RESULTS: This study included 197 patients with psoriasis and 401 controls. We found a higher prevalence of metabolic syndrome (17.8%, p=0.021), cardiovascular disease (4.6%, p=0.044), hypertension (32.5%, p=0.000) and hyperlipidemia (22.3%, p=0.025) in patients with psoriasis, as compared with that of the controls. To maintain proper LDL levels, 25.3% of the psoriasis patients needed lifestyle changes and 11.7% needed drug therapy. CONCLUSION: Our results demonstrate a possible association between psoriasis and cardiovascular diseases and their risk factors (metabolic syndrome, hypertension and hyperlipidemia) in Korean patients. We also demonstrated that a substantial portion of patients with psoriasis need lifestyle changes and drug therapy to prevent cardiovascular events. Further studies will be necessary to establish the association and causality between psoriasis and the cardiovascular risk factors.
28
Scott M. Grundy · JAMA · 1993 · 27.9K citations
Evaluation Expert Panel on Detection · JAMA · 2001 · 26K citations
Medicine, Cardiology, Otolaryngology +10
The metabolic syndrome—a new worldwide definition
K. G. M. M. Alberti, Paul Zimmet, Jonathan E. Shaw · The Lancet · 2005 · 9.3K citations
Validation of the Framingham Coronary Heart Disease Prediction Scores
Ralph B. D’Agostino, Scott M. Grundy, Lisa Sullivan et al. · JAMA · 2001 · 2.1K citations · Full text